These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38267696)

  • 1. Optimized Refolding Buffers Oriented Humoral Immune Responses Versus PfGCS1 Self-Assembled Peptide Nanoparticle.
    Nourani L; Lotfi A; Vand-Rajabpour H; Pourhashem Z; Nemati F; Mehrizi AA
    Mol Biotechnol; 2024 Sep; 66(9):2648-2664. PubMed ID: 38267696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and development of a self-assembling protein nanoparticle displaying PfHAP2 antigenic determinants recognized by natural acquired antibodies.
    Zahedi F; Abouie Mehrizi A; Sardari S; Alemzadeh I
    PLoS One; 2022; 17(9):e0274275. PubMed ID: 36094917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine.
    Pourhashem Z; Nourani L; Sani JJ; Yousefi H; Pirahmadi S; Sabouri M; Raz A; Djadid ND; Zakeri S; Mehrizi AA
    Malar J; 2023 Dec; 22(1):374. PubMed ID: 38071314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited genetic diversity and purifying selection in Iranian Plasmodium falciparum Generative Cell Specific 1 (PfGCS1), a potential target for transmission-blocking vaccine.
    Mehrizi AA; Zakeri S; Djadid ND
    Infect Genet Evol; 2014 Mar; 22():150-6. PubMed ID: 24462906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the heterologous expression and purification of Plasmodium falciparum generative cell specific 1 in Escherichia coli.
    Ayoub Meigouni M; Abouie Mehrizi A; Fazaeli A; Zakeri S; Djadid ND
    Protein Expr Purif; 2022 Oct; 198():106126. PubMed ID: 35661702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.
    Karch CP; Doll TAPF; Paulillo SM; Nebie I; Lanar DE; Corradin G; Burkhard P
    J Nanobiotechnology; 2017 Sep; 15(1):62. PubMed ID: 28877692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine.
    Howard GP; Bender NG; Khare P; López-Gutiérrez B; Nyasembe V; Weiss WJ; Simecka JW; Hamerly T; Mao HQ; Dinglasan RR
    Front Immunol; 2021; 12():729086. PubMed ID: 34512663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine.
    Guo Q; Dasgupta D; Doll TA; Burkhard P; Lanar DE
    Methods; 2013 May; 60(3):242-7. PubMed ID: 23548672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1 immune response to Plasmodium falciparum recombinant thrombospondin-related adhesive protein (TRAP) antigen is enhanced by TLR3-specific adjuvant, poly(I:C) in BALB/c mice.
    Mehrizi AA; Ameri Torzani M; Zakeri S; Jafary Zadeh A; Babaeekhou L
    Parasite Immunol; 2018 Jul; 40(7):e12538. PubMed ID: 29799636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the refolding conditions of self-assembling polypeptide nanoparticles that serve as repetitive antigen display systems.
    Yang Y; Ringler P; Müller SA; Burkhard P
    J Struct Biol; 2012 Jan; 177(1):168-76. PubMed ID: 22115997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
    Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
    PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.
    Fairley SJ; Singh SR; Yilma AN; Waffo AB; Subbarayan P; Dixit S; Taha MA; Cambridge CD; Dennis VA
    Int J Nanomedicine; 2013; 8():2085-99. PubMed ID: 23785233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor CD4
    Zaric M; Marini A; Nielsen CM; Gupta G; Mekhaiel D; Pham TP; Elias SC; Taylor IJ; de Graaf H; Payne RO; Li Y; Silk SE; Williams C; Hill AVS; Long CA; Miura K; Biswas S
    Front Immunol; 2021; 12():732667. PubMed ID: 34659219
    [No Abstract]   [Full Text] [Related]  

  • 17. Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine.
    Kaba SA; Karch CP; Seth L; Ferlez KMB; Storme CK; Pesavento DM; Laughlin PY; Bergmann-Leitner ES; Burkhard P; Lanar DE
    Vaccine; 2018 Feb; 36(6):906-914. PubMed ID: 29269157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.
    Kumar R; Angov E; Kumar N
    Infect Immun; 2014 Apr; 82(4):1453-9. PubMed ID: 24421036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein.
    Almeida AP; Dias MO; Vieira Cde A; Chávez-Olórtegui C; Gazzineli RT; Rodrigues MM; Fujiwara RT; Bruna-Romero O
    Vaccine; 2014 Apr; 32(19):2181-7. PubMed ID: 24582631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
    Miura K; Takashima E; Deng B; Tullo G; Diouf A; Moretz SE; Nikolaeva D; Diakite M; Fairhurst RM; Fay MP; Long CA; Tsuboi T
    Infect Immun; 2013 Dec; 81(12):4377-82. PubMed ID: 24042109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.